Literature DB >> 19635971

Electrocardiographic features of arrhythmogenic right ventricular dysplasia.

Rahul Jain1, Darshan Dalal, Amy Daly, Crystal Tichnell, Cynthia James, Ariana Evenson, Rohit Jain, Theodore Abraham, Boon Yew Tan, Hari Tandri, Stuart D Russell, Daniel Judge, Hugh Calkins.   

Abstract

BACKGROUND: The purpose of this study was to reevaluate the ECG features of arrhythmogenic right ventricular dysplasia (ARVD). The second objective was to evaluate the sensitivity and specificity of the standard and newly proposed diagnostic ECG markers in the presence of a right bundle-branch block (RBBB). METHODS AND
RESULTS: One hundred patients with ARVD (57 men; aged 39+/-15 years) and 57 controls (21 men; aged 40+/-17 years) were included. Among the 100 patients with ARVD, a complete RBBB was present in 17 patients, and 15 patients had an incomplete RBBB. T-wave inversion through V(3) demonstrated optimal sensitivity and specificity in both ARVD patients without a complete RBBB or incomplete RBBB (71% [95% confidence interval, 58% to 81%] and 96% [95% confidence interval, 81% to 100%], respectively) and in ARVD patients with incomplete RBBB (73% [95% confidence interval, 45% to 92%] and 95% [95% confidence interval, 77% to 100%], respectively). Between ARVD patients and controls with a complete RBBB, the only 2 parameters that differed were the prevalence of T-wave inversion through V(4) (59% versus 12%, respectively; P<0.05) and an r'/s ratio in V(1) <1 (88% versus 14%, respectively; P<0.005). In ARVD patients with complete RBBB, the most sensitive and specific parameter was an r'/s ratio <1.
CONCLUSIONS: We evaluated comprehensively the diagnostic value of ECG markers for ARVD. On the basis of the findings, we propose an algorithm, with examination of QRS morphology being the first step, for ECG evaluation of ARVD patients. Definite criteria are then applied on the basis of the presence of no RBBB, incomplete RBBB, and complete RBBB to obtain the best diagnostic utility of the ECG.

Entities:  

Mesh:

Year:  2009        PMID: 19635971      PMCID: PMC2814546          DOI: 10.1161/CIRCULATIONAHA.108.838821

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

1.  The value of different electrocardiographic depolarization criteria in the diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Stefan Peters; Martina Trümmel; Brigitte Koehler; Kai Uwe Westermann
Journal:  J Electrocardiol       Date:  2006-11-22       Impact factor: 1.438

2.  Arrhythmogenic right ventricular dysplasia: a United States experience.

Authors:  Darshan Dalal; Khurram Nasir; Chandra Bomma; Kalpana Prakasa; Harikrishna Tandri; Jonathan Piccini; Ariel Roguin; Crystal Tichnell; Cynthia James; Stuart D Russell; Daniel P Judge; Theodore Abraham; Philip J Spevak; David A Bluemke; Hugh Calkins
Journal:  Circulation       Date:  2005-12-12       Impact factor: 29.690

3.  DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Authors:  Mark M Awad; Darshan Dalal; Eunpi Cho; Nuria Amat-Alarcon; Cynthia James; Crystal Tichnell; April Tucker; Stuart D Russell; David A Bluemke; Harry C Dietz; Hugh Calkins; Daniel P Judge
Journal:  Am J Hum Genet       Date:  2006-04-28       Impact factor: 11.025

4.  Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2.

Authors:  Petros Syrris; Deirdre Ward; Alison Evans; Angeliki Asimaki; Estelle Gandjbakhch; Srijita Sen-Chowdhry; William J McKenna
Journal:  Am J Hum Genet       Date:  2006-09-27       Impact factor: 11.025

Review 5.  Arrhythmogenic right ventricular dysplasia.

Authors:  G Fontaine; F Fontaliran; J L Hébert; D Chemla; O Zenati; Y Lecarpentier; R Frank
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

6.  Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations.

Authors:  Barbara Bauce; Cristina Basso; Alessandra Rampazzo; Giorgia Beffagna; Luciano Daliento; Gianfranco Frigo; Sandro Malacrida; Luca Settimo; GianAntonio Danieli; Gaetano Thiene; Andrea Nava
Journal:  Eur Heart J       Date:  2005-06-07       Impact factor: 29.983

7.  Predictors of adverse outcome in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: long term experience of a tertiary care centre.

Authors:  K Lemola; C Brunckhorst; U Helfenstein; E Oechslin; R Jenni; F Duru
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

8.  A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy.

Authors:  Angeliki Asimaki; Petros Syrris; Thomas Wichter; Paul Matthias; Jeffrey E Saffitz; William J McKenna
Journal:  Am J Hum Genet       Date:  2007-09-28       Impact factor: 11.025

9.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology.

Authors:  W J McKenna; G Thiene; A Nava; F Fontaliran; C Blomstrom-Lundqvist; G Fontaine; F Camerini
Journal:  Br Heart J       Date:  1994-03

10.  Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis?

Authors:  C Basso; G Thiene; D Corrado; A Angelini; A Nava; M Valente
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

View more
  17 in total

1.  Usefulness of precordial T-wave inversion to distinguish arrhythmogenic right ventricular cardiomyopathy from idiopathic ventricular tachycardia arising from the right ventricular outflow tract.

Authors:  Daniel P Morin; Andreas C Mauer; Kathleen Gear; Wojciech Zareba; Steven M Markowitz; Frank I Marcus; Bruce B Lerman
Journal:  Am J Cardiol       Date:  2010-04-27       Impact factor: 2.778

Review 2.  The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.

Authors:  Mouaz H Al-Mallah; Mohammad Naseem Shareef
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

Review 3.  The year of 2009 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-10       Impact factor: 1.468

Review 4.  Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis.

Authors:  Hiroshi Satoh; Makoto Sano; Kenichiro Suwa; Takeji Saitoh; Mamoru Nobuhara; Masao Saotome; Tsuyoshi Urushida; Hideki Katoh; Hideharu Hayashi
Journal:  World J Cardiol       Date:  2014-07-26

Review 5.  Electrocardiographic T Wave Abnormalities and the Risk of Sudden Cardiac Death: The Finnish Perspective.

Authors:  Jani T Tikkanen; Tuomas Kenttä; Kimmo Porthan; Heikki V Huikuri; M Juhani Junttila
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-09-22       Impact factor: 1.468

Review 6.  [Prognostic significance of premature ventricular contractions : Harmless or life-threatening?]

Authors:  Shibu Mathew; Jörn Schmitt; Harilaos Bogossian
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-02-01

7.  Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.

Authors:  Kang Yin; Ligang Ding; Yuqiu Li; Wei Hua
Journal:  Clin Cardiol       Date:  2017-01-31       Impact factor: 2.882

Review 8.  Right bundle branch block and conduction disturbances in Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy.

Authors:  Leonardo Calò; Annamaria Martino; Emilia Goanta; Yasuo Okumura; Ermenegildo de Ruvo
Journal:  J Interv Card Electrophysiol       Date:  2018-05-26       Impact factor: 1.900

9.  Sports in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and desmosomal mutations.

Authors:  A C Sawant; H Calkins
Journal:  Herz       Date:  2015-05       Impact factor: 1.443

10.  Cardiac sarcoidosis and sudden death. The heart may look normal or mimic other cardiomyopathies.

Authors:  Izhar N Bagwan; Lucy V B Hooper; Mary N Sheppard
Journal:  Virchows Arch       Date:  2011-02-05       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.